Stockhead on MSN1h
Health Check: LTR Pharma finds fast-track path to US erectile dysfunction market
The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the US market.
ABP - Live on MSN9h
Punjab’s Determined Battle Against Drugs: A Vision for a Healthier Future
With a firm commitment to protecting its people, especially the youth, the Maan government has launched an all-out war ...
Aura Biosciences, Inc.: Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; Supports Front-Line Treatment Potential Clinical Pipeli ...
Intelligent Bio Solutions’ FDA Clearance Process Remains on Track for 2025 U.S. Launch
On December 18, 2024, the Company announced the submission of its 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for review and clearance of its Intelligent ...